Significant telomere reduction in human superficial transitional cell carcinoma

British Journal of Urology

Volumn 78, Issue 5, 1996, Pages 704-708

  Kamata, S ^a   Kageyama, Y ^a   Yonese, J ^a   Oshima, H ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Telomerase; Telomere length; Transitional cell carcinoma

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER INVASION; CANCER SURGERY; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TELOMERE; TRANSITIONAL CELL CARCINOMA;

EID: 0030406979     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1996.01957.x     Document Type: Article

References (30)

1. Blackburn EH. The molecular structure of centromeres and telomeres. Ann Rev Biochem 1984: 53: 163-94
2. Blackburn EH. Structure and function of telomeres. Nature 1991: 350: 569-573
3. Henderson E. Hardin C, Walk S. Tinoco TJ, Blackburn EH. Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine-guanine base pairs. Cell 1987; 51: 899-908
4. Balagurumoorthy P, Brahmachari SK. Structure and stability of human telomeric sequence. J Biol Chem 1994: 269: 21858-69
5. Moyzis RK, Buckingham JM, Cram LS et al. A highly conserved repetitive DNA sequence. (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988: 85: 6622-6
6. Allsopp RC, Vaziri H, Patterson C et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-8
7. Harley CB. Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Mature 1990; 345: 458-60
8. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256: 271-82
9. Counter CM, Avilion AA. LeFeuvre CE et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. Embo J 1992; 11: 1921-9
10. Klingelhutz AJ, Barber SA, Smith PP, Dyer K. McDougall JK. Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 1994; 14: 961-9
11. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nuture 1990: 346: 866-8
12. deLange T, Shiue L. Myers RM et al. Structure and variability of human chromosome ends. Mol Cell Rial 1990; 10: 518-27
13. Smith JK, Yeh G. Telomere reduction in endometrial adenocarcinoma. Am J Obstet Gynecol 1992; 167: 1883-7
14. Hiyama E, Hiyama K, Yokoyama T. Ichikawa T, Matsuura Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 1992; 83: 1 59-64
15. Odagiri E. Kanada N. Jibiki K, Demura R. Aikawa E, Demura H. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma. and gynecomastia. Relationship to histologie grade and clinical parameters. Cancer 1994; 73: 2978-84
16. Schwartz HS. Dahir GA. Butler MG. Telomere reduction in giant cell tumor of bone and with aging. Cancer Genet Cytogenet 1993: 71: 1 32-8
17. Hiyama E, Yokoyama T. Tatsumoto N et al. Telomerase activity in gastric cancer. Cancer Res 1995: 55: 5258-62
18. Ohyashiki JH. Ohyashiki K. Fujimura T et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994; 54: 3557-60
19. International Union Against Cancer. Urological tumors. In Hermanek P. Sobin LH eds, TNM Classification of Malignant Tumors. 4th edn. 2nd revision. Berlin: Springer-Verlag, 1992: 135-59
20. Japanese Urological Association and the Japanese Society of Pathology. General Rules for Clinical and Pathological Studies on Bladder Cancer, 2 edn. Tokyo: Kanehara Press. 1993
21. Gotoh S, Fukui I, Kobayashi T et al. Intra-arterial CDÜP and CDDP plus THP-ADM therapy for bladder cancer. Jpn J Urol 1993: 84: 1865-71
22. Sambrook J, Fritsch EF, Maniatis FT, eds. Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor. New York: Cold Spring Harbor Laboratory Press, 1989
23. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5
24. Kaighn ME. Narayan KS. Ohnuki Y. Lechner JF. Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17: 16-23
25. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91: 2900-4
26. Takada T, Hayashi T, Arakawa M, Kominami R. Telomere elongation frequently observed during tumor metastasis. Jpn J Cancer Res 1992; 83: 1124-7
27. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-20
28. Broccoli D, Young JW, de LT. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-6
29. Hiyama K, Hirai Y, Kyoizumi S et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-5
30. Tahara H, Nakanishi T, Kitamoto M et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-6